EANS-Adhoc: Capital increase to accompany Curanum's follow-up financing
-------------------------------------------------------------------------------- ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- 27.09.2012 In parallel with the follow-up financing for the borrower's note loan which is shortly to be concluded, the Management and Supervisory boards of Curanum AG have today passed a resolution to increase the company's share capital through issuing up to 3,315,000 ordinary bearer shares, each with a notional interest in the share capital of EUR 1.00 per share. To this end, the approved capital is to be completely utilized from currently EUR 39,192,000 to up to EUR 42,507,000 through granting subscription rights to all shareholders against cash. With the capital increase, not only is the operating business to be strengthened, but the company is also to be enabled to implement its future concepts which are oriented to further earnings improvement. The new shares will be offered to shareholders in a 11.7:1 ratio, at a subscription price of EUR 1.50 per share. The 405,102 treasury shares owned by the company will not participate in the subscription offer. The subscription offer will be published in the electronic Federal Gazette prospectively on October 2, 2012. The subscription period is set to run from October 4, 2012 until October 18, 2012. The stock market listing and delivery of the new shares to shareholders are planned to occur subsequently. The new shares are fully dividend-entitled for the 2012 financial year. The subscription offer is directed exclusively to existing shareholders. There are no plans to organize subscription rights trading. With the subscription offer, the right is also to be granted exclusively to the company's shareholders to acquire by way of oversubscription at the subscription price any new shares which have not been subscribed for by other shareholders. Binding offers for such oversubscriptions are to be submitted during the subscription period. If the allocation of additional requested new shares to all shareholders proves impossible due to high oversubscription demand, the company will decide at its due discretion concerning the allocation while complying with the principle of equal treatment. The new shares are to be admitted to trading on the Regulated Market (Prime Standard) on the Frankfurt Stock Exchange, without the publication of a securities prospectus. Further inquiry note: Caroline Lutz Leitung Unternehmensentwicklung Tel.: +49(0)89/ 24 20 65-0 E-Mail: ir@curanum.de end of announcement euro adhoc -------------------------------------------------------------------------------- issuer: CURANUM AG Engelbertstraße 23-25 D-81241 München phone: +49 (0)89 242065 51 FAX: +49 (0) 89 242065 10 mail: info@curanum.de WWW: http://www.curanum.de sector: Healthcare Providers ISIN: DE0005240709 indexes: CDAX, Classic All Share, Prime All Share stockmarkets: free trade: Berlin, Hamburg, Düsseldorf, Stuttgart, regulated dealing: München, regulated dealing/prime standard: Frankfurt language: English
Original content of: Korian GmbH, transmitted by news aktuell